Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease
about
Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus VariantsLeukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infectionsDiminished reovirus capsid stability alters disease pathogenesis and littermate transmissionThe GM2 Glycan Serves as a Functional Coreceptor for Serotype 1 ReovirusBid regulates the pathogenesis of neurotropic reovirus.Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines.Cancer screening by systemic administration of a gene delivery vector encoding tumor-selective secretable biomarker expressionOrgan-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease.Rotavirus viremia and extraintestinal viral infection in the neonatal rat model.The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease.Differential distribution of the JC virus receptor-type sialic acid in normal human tissues.Glycan engagement dictates hydrocephalus induction by serotype 1 reovirus.Reovirus receptors and pathogenesis.Mechanisms of reovirus bloodstream dissemination.Prediction of GCRV virus-host protein interactome based on structural motif-domain interactions.Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous systemFrom touchdown to transcription: the reovirus cell entry pathwayThe sweet spot: defining virus-sialic acid interactions.Directional release of reovirus from the apical surface of polarized endothelial cellsReovirus activates a caspase-independent cell death pathway.Aetiology of biliary atresia: what is actually known?Clues to the etiology of bile duct injury in biliary atresiaRecent Advances in Etiology of Biliary Atresia.Utilization of sialylated glycans as coreceptors enhances the neurovirulence of serotype 3 reovirus.Junctional adhesion molecule a serves as a receptor for prototype and field-isolate strains of mammalian reovirus.The reovirus sigma1s protein is a determinant of hematogenous but not neural virus dissemination in mice.Nonstructural protein σ1s mediates reovirus-induced cell cycle arrest and apoptosis.Intestinal microbiota promote enteric virus replication and systemic pathogenesis.Optimum length and flexibility of reovirus attachment protein σ1 are required for efficient viral infection.Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis.Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses.Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid bindingA new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptorsNonstructural protein sigma1s is a determinant of reovirus virulence and influences the kinetics and severity of apoptosis induction in the heart and central nervous system.Viral gene expression potentiates reovirus-induced necrosis.Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia.The bulky and the sweet: How neutralizing antibodies and glycan receptors compete for virus binding.Junctional adhesion molecule-A is required for hematogenous dissemination of reovirusInterferon regulatory factor 3 attenuates reovirus myocarditis and contributes to viral clearance.
P2860
Q26775033-01BA381D-CB1B-4525-B362-1FF1D9764DEBQ27320523-FC63DB4E-2D96-4177-9CFF-AFD04F7F5371Q27321066-6D8804EB-8F3D-4B8F-8855-08E17BDCAE11Q27675479-E32E1473-B86C-4EDA-BCC7-0D48FD4E97CAQ33628824-E4163BB0-B92E-4E7D-A837-907C3B1DA0DDQ33788674-EABE4ABA-B838-4978-A544-C432048B93DEQ33903856-682D9C73-09E9-4C0F-98A6-D9561D4E1D95Q33914633-A9FF27CE-B4FA-484E-80AB-31E39A5AF4E8Q34647817-465417DA-226D-4B06-BF3B-DA70B8D9DBE3Q34660377-55B81F58-8978-416A-B9D4-58F6EDAEF51BQ35083490-3E6E1181-5988-451E-B47C-100DC6136822Q35172332-021DB923-7698-46F9-9CB9-A2C47A5CED5DQ35198395-90FD3E9A-236F-4D2C-A0D5-10307FF675D0Q36155563-DB89098D-0D24-428B-BA73-850B7B273C3BQ36295738-D3767CD4-6965-42B3-89C9-2B4FB2F4698EQ36373033-35E1A292-8804-4DA7-A201-DAFC345E4C86Q36467525-C03C377F-01F2-4C8D-8A09-40A2D478DD30Q36685206-361FC51B-2A6F-4760-B31F-F5023E27D9CBQ36756605-9AB2DE6E-570C-445F-A483-65BE2CE42965Q36850813-E3165E61-68C5-44EC-90A8-931BC6F363EFQ37153740-2A81F12D-BDC4-4479-A743-D2E6C1A44DD0Q37308079-288C84E8-D3DF-474C-9558-E62C9A3979FAQ38245985-10872640-28D7-4CAF-B1CB-E40746D06279Q38321111-62D7128A-45DA-4CDD-B8D0-E4A6C370E282Q38324922-2FEE35E0-19E0-4C9A-B266-197DA371D362Q38959464-987C0A50-6E1A-4DC0-8850-BFBDC2802A28Q39091807-E7CFDF7D-A41A-4D65-8590-69D66DE6FE11Q39306213-94DA8B7D-CDD4-4274-821F-A7C17B12E157Q39312059-B57FAA59-3653-464A-A51E-CAE5B418F5D7Q39819247-DC9B6C7E-6ED7-4FF5-A222-6D1417B0A14FQ39879555-0DE55188-34B0-4285-A89B-CBBC134DFB6BQ39900629-63EA5D93-54AD-4486-A5D9-C305D1812685Q40223632-F3DA8477-C0D2-476C-9CB1-F34AA0FC04DCQ40530718-98911473-4E3E-4D90-9C91-24A6F24349A7Q41056427-E0D68FAF-2BD2-4BE4-802E-E59C72702CD7Q41080969-6BCAEAC5-9C7D-420B-9633-CF081A45A724Q41345437-CB3A3F86-46C4-4E58-9D15-1CC1A8A7B01EQ41922286-D9C5958E-F4B7-4D2D-876E-D3C42E338DB5Q42085912-3954A0D3-1372-492D-B7A8-1236C1295BA7Q42092082-DBA0AA6F-8335-45EA-9E2C-F43BEEC14ACF
P2860
Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Utilization of sialic acid as ...... ovirus-induced biliary disease
@ast
Utilization of sialic acid as ...... ovirus-induced biliary disease
@en
type
label
Utilization of sialic acid as ...... ovirus-induced biliary disease
@ast
Utilization of sialic acid as ...... ovirus-induced biliary disease
@en
prefLabel
Utilization of sialic acid as ...... ovirus-induced biliary disease
@ast
Utilization of sialic acid as ...... ovirus-induced biliary disease
@en
P2093
P2860
P356
P1476
Utilization of sialic acid as ...... ovirus-induced biliary disease
@en
P2093
Bryan E Youree
Daniel H Ebert
Erik S Barton
J Craig Forrest
J Denise Wetzel
Jodi L Connolly
Kay Washington
Terence S Dermody
Tibor Valyi-Nagy
P2860
P304
P356
10.1172/JCI16303
P407
P577
2003-06-01T00:00:00Z